Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Apimeds Pharmaceuticals US, Inc. (APUS)

Apimeds unit MindWave signs two-year BlockAssure blockchain build-and-operate agreement

Neutral Impact 3 of 5 product/contract Written later

Apimeds subsidiary MindWave Innovations signed a two-year Master Service Agreement with BlockAssure Inc. to build, deploy and operate AssureChain, a dedicated subnet of MindChain for recording BlockAssure's insurance and reinsurance processes on-chain. The filing does not disclose a dollar value for the fixed development fee, and operate and maintenance fees are still to be agreed, so the financial effect on shareholders cannot be measured from the filing.

Key points

  • Agreement took effect October 4, 2026; it renews automatically for one-year periods unless either party gives 90 days' notice.
  • Consideration includes a fixed development fee payable in quarterly installments, with no dollar amount stated in the filing.
  • MindWave is to receive an allocation of AssureCoin equal to 20% of its total supply, delivered when the token is created.
  • Development is planned over four quarters against agreed milestones, with BlockAssure acceptance-testing each module.

The filing

CompanyApimeds Pharmaceuticals US, Inc. (APUS)
Form8-K, current report
Filed with the SECOct 13, 2026, 9:10 AM ET
Accession number0001213900-26-108780

Items reported: 8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:44 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 13, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.